MedPath

Thoracic Combined Spinal Epidural Anesthesia for Breast Surgery

Completed
Conditions
Pain
Breast Diseases
Registration Number
NCT04706247
Lead Sponsor
Antalya Training and Research Hospital
Brief Summary

The aim of the study is to investigate the efficacy of the thoracic combined spinal epidural anesthesia in breast surgery.

Detailed Description

Previous studies of the regional anesthetic techniques such as erector spinae plane block and pectoralis nerve blocks (PECs blocks) additional to general anesthesia have described their use for postoperative analgesia in breast surgery. It has been also reported that these blocks can be used to provide surgical anesthesia in breast surgery . Segmental thoracic epidural anesthesia can be used as an alternative anesthetic technique in patients with severe chronic obstructive pulmonary disease and asthma undergoing breast surgery. It has been also reported that thoracic spinal anesthesia was effective and successful in patients undergoing laparoscopic surgery. In this study, efficacy of high thoracic spinal epidural anesthesia in patients undergoing breast surgery will be evaluated.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
26
Inclusion Criteria
  • Patients who will be to undergo elective surgery for breast surgery
  • American Society of Anesthesiologists (ASA) physical status classification groups I or II
Exclusion Criteria
  • body mass index>35 kg/m2,
  • presence of any condition complicating and contraindicating spinal epidural anesthesia.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Block successthrough study completion, an average of 3 months

the number of patients whose surgery was completed without general anesthesia

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Antalya Training and Research Hospital

🇹🇷

Antalya, Turkey

Antalya Training and Research Hospital
🇹🇷Antalya, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.